Centene downgraded to Sell from Neutral at Citigroup Citigroup downgraded Centene (CNC) to Sell saying that Ascension Health is not buying a publicly traded health plan, as has been speculated. Citi notes that in a recent bond document, Ascension stated that it has entered into a non-binding letter of intent to buy an insurance company, saying the purchase price "would not be material." Shares of Centene (CNC) and WellCare (WCG) rallied last week on the speculation, the firm points out. Citi sees near-term earnings risk for Centene and keeps a $65 price target for shares.
WellCare valuation compelling after selloff, says Leerink Leerink views the valuation of WellCare shares as compelling following the company's "solid" Q1 results. The firm reiterates an Outperform rating on the stock with a $105 price target.